The Best AI for Bioinformatics Is a Coding Agent

The best general-purpose AI for bioinformatics today is a frontier large language model driven as a coding agent over your actual files: Claude Code, Codex CLI, or the same class of model inside Cursor or Aider. It is best not because it knows biology but because most bioinformatics work is file wrangling, format conversion, and statistics in Python and R. Separately, there is a second category that people confuse with the first. Task-specific models like AlphaFold, ESM-2, and AlphaMissense make predictions rather than write code. You want both, and you want to know which one you are using at any moment.

What you should not do is treat a chat window as an oracle for biological facts. Benchmarks of LLMs across defined bioinformatics tasks show uneven performance, with strong results on some and clear failures on others, including reasoning that looks fluent while being wrong ¹. The fluency is the hazard. A wrong bcftools flag throws an error. A wrong claim about a variant does not.

Why the coding agent is the right unit of work

Look at what you do in a day with a personal molecular dataset. You have a VCF of roughly 4 to 5 million variants from whole-genome sequencing and a quant.sf or counts matrix from RNA sequencing. You also have an Olink or mass-spec proteomics table in long format, a CSV of blood panels over time, and CGM export at 5-minute resolution. Almost every question you have is a join, a filter, a normalization, or a regression across those files.

That is software work, and the agent is good at it. Ask it to parse the CGM export, resample to 15 minutes, and compute time in range per day. It will write correct pandas in one pass. Ask it to reshape a long-format proteomics table into a subject-by-protein matrix and plot each protein against draw date, and it will do that too. Reviews of AI in genomic analysis describe the same division of labor: models accelerate the computational layer around established pipelines rather than replacing the pipelines ².

The productivity gain comes from the agent having a shell. It runs the command, reads the traceback, and fixes it. Web chat without file access will confidently produce a bcftools invocation with a flag that was removed three versions ago, and you will discover it yourself. Give the agent a terminal and it discovers it in two seconds.

A setup we would use

We run analysis in a container so the agent can install things without breaking anything that matters. A concrete starting point:

• A Docker image on mambaorg/micromamba with the following.
  • bcftools 1.20+
  • samtools
  • ensembl-vep
  • salmon
  • bedtools
  • Python 3.11 with four packages: pandas, pysam, scikit-allel and statsmodels
  • R with DESeq2 and data.table
• Read-only bind mount for raw data. Your CRAM, VCF, and FASTQ are immutable inputs. Nothing in the agent’s path should be able to overwrite them.
• A separate work/ directory for derived files, with a Makefile or a Snakemake file so each step is reproducible.
• git initialized on day one, with a .gitignore for anything over a few megabytes.

Then give the agent a short project file describing the data. Genome build (GRCh38 versus GRCh37), whether contigs carry a chr prefix, caller and version, coverage, and the exact columns of every tabular file. Half of the agent’s mistakes in genomics come from guessing these, and a 15-line context file removes them.

For annotation, we prefer VEP with a local cache over any API. Something like vep --cache --offline --assembly GRCh38 --everything --vcf --fork 4, then bcftools +split-vep to pull the CSQ subfields you care about into INFO tags you can filter on. Before any of it, normalize: bcftools norm -m -any -f GRCh38.fa -c s. Skipping normalization is the single most common source of joins that silently lose indels.

Where task-specific models fit

The prediction models are a different tool with a different failure mode. ESM-2 gives you protein embeddings and variant likelihoods from sequence alone. AlphaFold and its successors give structure. AlphaMissense gives a pathogenicity score per missense substitution, and it is already available as a precomputed table you can join against your VCF by chromosome, position, ref, and alt. Enformer and related models predict regulatory signal from sequence. For single-cell or bulk expression work there are foundation models such as scGPT and Geneformer.

Two rules for all of them. First, a score is a prior rather than a finding. The training data behind these models is skewed toward well-studied genes and European-ancestry cohorts ². Second, join on coordinates and alleles rather than on gene symbols. Gene symbols alias, get renamed, and get mangled by spreadsheets. Use Ensembl gene IDs with an explicit release number.

There is also an emerging class of tools that recommends analyses rather than performing them. Recommender systems for biomedical machine learning have been evaluated and shown to improve over random pipeline selection in controlled settings ³. Useful as a search strategy over the hyperparameter space. Not a substitute for knowing what your outcome variable is.

The failure modes to watch for

These are the ones that cost us real time, and the ones an agent will not catch unless you ask.

Coordinate conventions. VCF is 1-based and inclusive. BED is 0-based and half-open. An off-by-one in a bedtools intersect produces a plausible answer with the wrong variants.

Build mismatch. A GRCh37 position matched against GRCh38 annotation returns hits. They are the wrong hits. Check the VCF header contig lengths before trusting anything.

Strand and allele orientation. Polygenic score weights and GWAS summary statistics are published against a specific effect allele. Flip it and your score inverts. Verify against allele frequency in a reference panel rather than assuming.

Multiple testing. If you regress 3,000 proteins against one CGM metric, you will get roughly 150 hits at p < 0.05 from noise alone. Ask for Benjamini-Hochberg FDR and report it.

Batch effects in longitudinal data. Two proteomics draws processed on different plates differ by plate. The difference does not come from biology. Include a batch term or normalize within batch. This is the dominant artifact in any personal time series with irregular sample collection.

Agents will also happily fabricate a citation for a biological claim. Ask for a PubMed ID, then check it. Treat every unverified biological assertion as a hypothesis to look up, which is the posture the benchmark results support ¹.

Compute, briefly

You do not need a cluster for one person’s data. A machine with 8 to 16 cores, 64 GB of RAM, and 2 TB of fast local storage is enough. It handles alignment, joint annotation, and every downstream analysis described here. RAM is the binding constraint for variant-level work, and disk is the constraint if you keep FASTQ alongside CRAM. Scaling AI methods to population-size cohorts is where HPC becomes the real question ⁴.

Where a clinician is required

Everything above is measurement and interpretation of your own data. Any question about what a finding means for your health, whether to act on it, or whether a variant is clinically relevant belongs with a physician or a board-certified genetic counselor. Research-grade annotation is not a clinical result, and an incidental finding in a cancer predisposition or cardiac gene should go to a clinician rather than to your agent. Confirmatory clinical-grade testing is a separate step and a clinician orders it.

Questions people also ask

Which AI is best for bioinformatics? For writing and running analysis code, a frontier LLM used as an agent with shell access to your files. For prediction on sequence or structure, a task-specific model such as ESM-2, AlphaFold, or AlphaMissense. There is no single model that does both well.

Is AI going to replace bioinformatics? It is replacing the hours spent on format conversion and boilerplate plotting. It does not decide what the right comparison is, whether a batch effect is confounding a result, or whether a dataset can answer the question asked of it. Published reviews frame AI as extending existing analysis rather than substituting for the analyst ².

What are some good AI courses for bioinformatics? Learn the statistics and the file formats first. A solid path is Rafael Irizarry’s Data Analysis for the Life Sciences series, the Bioconductor workflow vignettes for DESeq2 and limma, and then a general deep learning course such as fast.ai. Bio-specific AI courses are weaker than general ML courses plus domain reading.

What are the big three in bioinformatics? The phrase usually refers to the major sequence databases: GenBank at NCBI, the European Nucleotide Archive at EMBL-EBI, and the DNA Data Bank of Japan. They exchange records daily through the International Nucleotide Sequence Database Collaboration.

Footnotes

1. Serghei Mangul, Varuni Sarwal, Viorel Munteanu, et al. BioLLMBench: A Comprehensive Benchmarking of Large Language Models in Bioinformatics. 2024. https://doi.org/10.21203/rs.3.rs-3780193/v1 ↩ ↩²

2. David B. Olawade, Ayomikun Kade, Eghosasere Egbon, et al. Bioinformatics and artificial intelligence in genomic data analysis: current advances and future directions. Molecular Genetics and Genomics, 2025. https://doi.org/10.1007/s00438-025-02314-x ↩ ↩² ↩³

3. William La Cava, Heather Williams, Weixuan Fu, et al. Evaluating recommender systems for AI-driven biomedical informatics. Bioinformatics, 2020. https://doi.org/10.1093/bioinformatics/btaa698 ↩

4. Yanjie Wei, Weiguo Liu, Bertil Schmidt, et al. HPC and AI in bioinformatics. Future Generation Computer Systems, 2026. https://doi.org/10.1016/j.future.2025.108019 ↩